The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2020-04-22

AUTHORS

Yoji Miyahara, Shida Takashi, Yoshiaki Shimizu, Masayuki Ohtsuka

ABSTRACT

BackgroundA growing body of evidence suggests that inflammatory response markers such as the neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) are associated with outcomes of various malignancies. However, no study has reported the prognostic value of NLR and LMR in patients with distal bile duct cancer (DBDC) to date. We investigated the prognostic significance of these inflammatory markers in patients with DBDC who underwent radical resection.MethodsThe study included 40 patients diagnosed with DBDC who underwent pancreaticoduodenectomy at Narita Red Cross Hospital between January 2000 and December 2017. The cutoff values for these markers were determined by receiver operating characteristic curve analysis. Survival curves are estimated for each group in the study considered separately using the Kaplan-Meier method. The association between overall survival (OS) and the NLR, LMR, and other prognostic factors was investigated using log-rank test and multivariate Cox proportional hazards regression analysis.ResultsCorresponding to the point with the maximum combined sensitivity and specificity on the ROC curve, the best cutoff value for NLR and LMR was determined to be 3.14 and 4.55, respectively. Most clinicopathological factors were not associated with the NLR and LMR based on these cutoff values. However, serum albumin levels were associated with both the NLR and LMR (P = 0.011 and P = 0.023, respectively), and serum carbohydrate antigen 19-9 (CA 19-9) levels were also associated with the LMR (P = 0.030). Univariate analysis showed that a high NLR (P < 0.001), low LMR (P = 0.002), hypoalbuminemia (P = 0.004), high serum CA 19-9 levels (P = 0.008), and lymph node metastasis (P = 0.033) were significantly associated with poor survival rates. Multivariate analysis showed that a high NLR (hazard ratio 5.799, 95% confidence interval 1.188–28.32, P = 0.030) and a low LMR (hazard ratio 4.837, 95% confidence interval 1.826–2.331, P = 0.025) were independent prognostic factors for OS.ConclusionBoth NLR and LMR may serve as significant independent preoperative prognostic indicators of disease in patients with DBDC who undergo radical resection. More... »

PAGES

78

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12957-020-01847-2

DOI

http://dx.doi.org/10.1186/s12957-020-01847-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1126893504

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/32321522


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bile Duct Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bile Ducts, Extrahepatic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Inflammation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphatic Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Monocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neutrophils", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreaticoduodenectomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Preoperative Period", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ROC Curve", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8677, Chiba-shi, Chiba Prefecture, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of Surgery, Japanese Red Cross Narita Hospital, 90-1 Iida-cho, 286-0041, Narita-shi, Chiba Prefecture, Japan", 
            "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8677, Chiba-shi, Chiba Prefecture, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyahara", 
        "givenName": "Yoji", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Shida Clinic, 1970-1-2 Ne, 270-1431, Shiroi-shi, Chiba Prefecture, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Shida Clinic, 1970-1-2 Ne, 270-1431, Shiroi-shi, Chiba Prefecture, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takashi", 
        "givenName": "Shida", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Japanese Red Cross Narita Hospital, 90-1 Iida-cho, 286-0041, Narita-shi, Chiba Prefecture, Japan", 
          "id": "http://www.grid.ac/institutes/grid.459661.9", 
          "name": [
            "Department of Surgery, Japanese Red Cross Narita Hospital, 90-1 Iida-cho, 286-0041, Narita-shi, Chiba Prefecture, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shimizu", 
        "givenName": "Yoshiaki", 
        "id": "sg:person.0757552432.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757552432.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8677, Chiba-shi, Chiba Prefecture, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8677, Chiba-shi, Chiba Prefecture, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohtsuka", 
        "givenName": "Masayuki", 
        "id": "sg:person.0653527253.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653527253.30"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nature04870", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043364117", 
          "https://doi.org/10.1038/nature04870"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12032-014-0287-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022955166", 
          "https://doi.org/10.1007/s12032-014-0287-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature07205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024729982", 
          "https://doi.org/10.1038/nature07205"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12885-017-3395-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085872486", 
          "https://doi.org/10.1186/s12885-017-3395-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature06905", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029740181", 
          "https://doi.org/10.1038/nature06905"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature13111", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046208212", 
          "https://doi.org/10.1038/nature13111"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2009.416", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042063808", 
          "https://doi.org/10.1038/onc.2009.416"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri1995", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052092567", 
          "https://doi.org/10.1038/nri1995"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-04-22", 
    "datePublishedReg": "2020-04-22", 
    "description": "BackgroundA growing body of evidence suggests that inflammatory response markers such as the neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) are associated with outcomes of various malignancies. However, no study has reported the prognostic value of NLR and LMR in patients with distal bile duct cancer (DBDC) to date. We investigated the prognostic significance of these inflammatory markers in patients with DBDC who underwent radical resection.MethodsThe study included 40 patients diagnosed with DBDC who underwent pancreaticoduodenectomy at Narita Red Cross Hospital between January 2000 and December 2017. The cutoff values for these markers were determined by receiver operating characteristic curve analysis. Survival curves are estimated for each group in the study considered separately using the Kaplan-Meier method. The association between overall survival (OS) and the NLR, LMR, and other prognostic factors was investigated using log-rank test and multivariate Cox proportional hazards regression analysis.ResultsCorresponding to the point with the maximum combined sensitivity and specificity on the ROC curve, the best cutoff value for NLR and LMR was determined to be 3.14 and 4.55, respectively. Most clinicopathological factors were not associated with the NLR and LMR based on these cutoff values. However, serum albumin levels were associated with both the NLR and LMR (P = 0.011 and P = 0.023, respectively), and serum carbohydrate antigen 19-9 (CA 19-9) levels were also associated with the LMR (P = 0.030). Univariate analysis showed that a high NLR (P < 0.001), low LMR (P = 0.002), hypoalbuminemia (P = 0.004), high serum CA 19-9 levels (P = 0.008), and lymph node metastasis (P = 0.033) were significantly associated with poor survival rates. Multivariate analysis showed that a high NLR (hazard ratio 5.799, 95% confidence interval 1.188\u201328.32, P = 0.030) and a low LMR (hazard ratio 4.837, 95% confidence interval 1.826\u20132.331, P = 0.025) were independent prognostic factors for OS.ConclusionBoth NLR and LMR may serve as significant independent preoperative prognostic indicators of disease in patients with DBDC who undergo radical resection.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12957-020-01847-2", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1032056", 
        "issn": [
          "1477-7819"
        ], 
        "name": "World Journal of Surgical Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "keywords": [
      "distal bile duct cancer", 
      "bile duct cancer", 
      "overall survival", 
      "cutoff value", 
      "monocyte ratio", 
      "high NLR", 
      "duct cancer", 
      "radical resection", 
      "prognostic factors", 
      "low LMR", 
      "lymphocyte ratio", 
      "Cox proportional hazards regression analysis", 
      "Narita Red Cross Hospital", 
      "high serum CA 19", 
      "serum carbohydrate antigen 19", 
      "proportional hazards regression analysis", 
      "serum albumin level", 
      "serum CA 19", 
      "Kaplan-Meier method", 
      "independent prognostic factor", 
      "inflammatory response markers", 
      "hazards regression analysis", 
      "lymph node metastasis", 
      "log-rank test", 
      "carbohydrate antigen 19", 
      "Red Cross Hospital", 
      "best cutoff value", 
      "poor survival rate", 
      "characteristic curve analysis", 
      "preoperative prognostic indicators", 
      "inflammatory markers", 
      "prognostic impact", 
      "clinicopathological factors", 
      "albumin levels", 
      "node metastasis", 
      "prognostic value", 
      "prognostic significance", 
      "antigen 19", 
      "CA 19", 
      "prognostic indicator", 
      "body of evidence", 
      "univariate analysis", 
      "MethodsThe study", 
      "response markers", 
      "patients", 
      "survival rate", 
      "survival curves", 
      "multivariate analysis", 
      "NLR", 
      "curve analysis", 
      "ROC curve", 
      "resection", 
      "LMR", 
      "regression analysis", 
      "lymphocytes", 
      "cancer", 
      "markers", 
      "pancreaticoduodenectomy", 
      "hypoalbuminemia", 
      "malignancy", 
      "metastasis", 
      "hospital", 
      "factors", 
      "levels", 
      "disease", 
      "BackgroundA", 
      "study", 
      "survival", 
      "outcomes", 
      "association", 
      "group", 
      "specificity", 
      "evidence", 
      "ratio", 
      "analysis", 
      "significance", 
      "sensitivity", 
      "rate", 
      "date", 
      "curves", 
      "test", 
      "values", 
      "body", 
      "indicators", 
      "receiver", 
      "impact", 
      "method", 
      "point"
    ], 
    "name": "The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer", 
    "pagination": "78", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1126893504"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12957-020-01847-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "32321522"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12957-020-01847-2", 
      "https://app.dimensions.ai/details/publication/pub.1126893504"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:47", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_851.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12957-020-01847-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12957-020-01847-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12957-020-01847-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12957-020-01847-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12957-020-01847-2'


 

This table displays all metadata directly associated to this object as RDF triples.

294 TRIPLES      21 PREDICATES      143 URIs      127 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12957-020-01847-2 schema:about N21963b74d5224e7c8a086f8f77e264be
2 N24902dcfd0c94d40878fcf6e5925c87a
3 N3a57d73a704447069a6950a451c786b1
4 N3c37e1fcf567441b8113d89f65c40f5d
5 N4109151d029a4c93992f27a1d288f19c
6 N50d4807d8ff94bc8afc21fb06c25b012
7 N63dd8acd08cf4d72939c3f1b5d55e5f4
8 N7363486b6038483ea3b8d00af86aafdd
9 N840dea894a31485cb2c7d46d2d32be8b
10 N8a6a98cb92c14a8fbbba788ae128dcdf
11 N8bf0e104a1c04369892c4668bce1f009
12 N8fa8a43910bd4488bcb91f93c4399953
13 Nb69fa576dfd54b10a0e65c38e9c85e00
14 Nc2d89d1b3845453b8de3ddb39d723577
15 Nc940f1b0da29480381c2ad94d46bb4f0
16 Nd28879f43ab84405bb5f155d3a8c73db
17 Nd4a7cd1cf97c4790afebf28627f3b3f3
18 Nd8a1fbd3984d4195888319a042edff2e
19 Nd9d4851b5069462d8cd6c602014aa5a6
20 Ne398474f4d754e21a06f47943efbdd24
21 Ned045f187f714e7d8c12f72f0c2c1300
22 Nf9271c24690844dfa348dcba36e994bb
23 anzsrc-for:11
24 anzsrc-for:1112
25 schema:author Naf06e03d0e004536b6c376913b660890
26 schema:citation sg:pub.10.1007/s12032-014-0287-y
27 sg:pub.10.1038/nature04870
28 sg:pub.10.1038/nature06905
29 sg:pub.10.1038/nature07205
30 sg:pub.10.1038/nature13111
31 sg:pub.10.1038/nri1995
32 sg:pub.10.1038/onc.2009.416
33 sg:pub.10.1186/s12885-017-3395-1
34 schema:datePublished 2020-04-22
35 schema:datePublishedReg 2020-04-22
36 schema:description BackgroundA growing body of evidence suggests that inflammatory response markers such as the neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) are associated with outcomes of various malignancies. However, no study has reported the prognostic value of NLR and LMR in patients with distal bile duct cancer (DBDC) to date. We investigated the prognostic significance of these inflammatory markers in patients with DBDC who underwent radical resection.MethodsThe study included 40 patients diagnosed with DBDC who underwent pancreaticoduodenectomy at Narita Red Cross Hospital between January 2000 and December 2017. The cutoff values for these markers were determined by receiver operating characteristic curve analysis. Survival curves are estimated for each group in the study considered separately using the Kaplan-Meier method. The association between overall survival (OS) and the NLR, LMR, and other prognostic factors was investigated using log-rank test and multivariate Cox proportional hazards regression analysis.ResultsCorresponding to the point with the maximum combined sensitivity and specificity on the ROC curve, the best cutoff value for NLR and LMR was determined to be 3.14 and 4.55, respectively. Most clinicopathological factors were not associated with the NLR and LMR based on these cutoff values. However, serum albumin levels were associated with both the NLR and LMR (P = 0.011 and P = 0.023, respectively), and serum carbohydrate antigen 19-9 (CA 19-9) levels were also associated with the LMR (P = 0.030). Univariate analysis showed that a high NLR (P < 0.001), low LMR (P = 0.002), hypoalbuminemia (P = 0.004), high serum CA 19-9 levels (P = 0.008), and lymph node metastasis (P = 0.033) were significantly associated with poor survival rates. Multivariate analysis showed that a high NLR (hazard ratio 5.799, 95% confidence interval 1.188–28.32, P = 0.030) and a low LMR (hazard ratio 4.837, 95% confidence interval 1.826–2.331, P = 0.025) were independent prognostic factors for OS.ConclusionBoth NLR and LMR may serve as significant independent preoperative prognostic indicators of disease in patients with DBDC who undergo radical resection.
37 schema:genre article
38 schema:isAccessibleForFree true
39 schema:isPartOf N58aaa8111d544e02a213d2208e9d3435
40 N5d8586c3f82547d496cd7f867b584602
41 sg:journal.1032056
42 schema:keywords BackgroundA
43 CA 19
44 Cox proportional hazards regression analysis
45 Kaplan-Meier method
46 LMR
47 MethodsThe study
48 NLR
49 Narita Red Cross Hospital
50 ROC curve
51 Red Cross Hospital
52 albumin levels
53 analysis
54 antigen 19
55 association
56 best cutoff value
57 bile duct cancer
58 body
59 body of evidence
60 cancer
61 carbohydrate antigen 19
62 characteristic curve analysis
63 clinicopathological factors
64 curve analysis
65 curves
66 cutoff value
67 date
68 disease
69 distal bile duct cancer
70 duct cancer
71 evidence
72 factors
73 group
74 hazards regression analysis
75 high NLR
76 high serum CA 19
77 hospital
78 hypoalbuminemia
79 impact
80 independent prognostic factor
81 indicators
82 inflammatory markers
83 inflammatory response markers
84 levels
85 log-rank test
86 low LMR
87 lymph node metastasis
88 lymphocyte ratio
89 lymphocytes
90 malignancy
91 markers
92 metastasis
93 method
94 monocyte ratio
95 multivariate analysis
96 node metastasis
97 outcomes
98 overall survival
99 pancreaticoduodenectomy
100 patients
101 point
102 poor survival rate
103 preoperative prognostic indicators
104 prognostic factors
105 prognostic impact
106 prognostic indicator
107 prognostic significance
108 prognostic value
109 proportional hazards regression analysis
110 radical resection
111 rate
112 ratio
113 receiver
114 regression analysis
115 resection
116 response markers
117 sensitivity
118 serum CA 19
119 serum albumin level
120 serum carbohydrate antigen 19
121 significance
122 specificity
123 study
124 survival
125 survival curves
126 survival rate
127 test
128 univariate analysis
129 values
130 schema:name The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer
131 schema:pagination 78
132 schema:productId N33a1b71759fc45ac933e105744245ae0
133 Na22068ce13064796ab83bc984960f2f4
134 Nb44f97d796734b06815df7b4910d4087
135 schema:sameAs https://app.dimensions.ai/details/publication/pub.1126893504
136 https://doi.org/10.1186/s12957-020-01847-2
137 schema:sdDatePublished 2022-10-01T06:47
138 schema:sdLicense https://scigraph.springernature.com/explorer/license/
139 schema:sdPublisher N9c2f62048bc74a96964a3f06e6dc2abb
140 schema:url https://doi.org/10.1186/s12957-020-01847-2
141 sgo:license sg:explorer/license/
142 sgo:sdDataset articles
143 rdf:type schema:ScholarlyArticle
144 N0ca50429ff93467ba795cdc88eaa88be rdf:first sg:person.0653527253.30
145 rdf:rest rdf:nil
146 N21963b74d5224e7c8a086f8f77e264be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Middle Aged
148 rdf:type schema:DefinedTerm
149 N24902dcfd0c94d40878fcf6e5925c87a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Neutrophils
151 rdf:type schema:DefinedTerm
152 N33a1b71759fc45ac933e105744245ae0 schema:name pubmed_id
153 schema:value 32321522
154 rdf:type schema:PropertyValue
155 N3a57d73a704447069a6950a451c786b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Pancreaticoduodenectomy
157 rdf:type schema:DefinedTerm
158 N3c37e1fcf567441b8113d89f65c40f5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Bile Ducts, Extrahepatic
160 rdf:type schema:DefinedTerm
161 N4109151d029a4c93992f27a1d288f19c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Female
163 rdf:type schema:DefinedTerm
164 N4fab78a9c3d542348a70f1f00605e7c9 rdf:first sg:person.0757552432.04
165 rdf:rest N0ca50429ff93467ba795cdc88eaa88be
166 N50d4807d8ff94bc8afc21fb06c25b012 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name ROC Curve
168 rdf:type schema:DefinedTerm
169 N529d696075544552b50377d2c8ded4b7 schema:affiliation grid-institutes:grid.136304.3
170 schema:familyName Miyahara
171 schema:givenName Yoji
172 rdf:type schema:Person
173 N58aaa8111d544e02a213d2208e9d3435 schema:volumeNumber 18
174 rdf:type schema:PublicationVolume
175 N5d8586c3f82547d496cd7f867b584602 schema:issueNumber 1
176 rdf:type schema:PublicationIssue
177 N63dd8acd08cf4d72939c3f1b5d55e5f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Inflammation
179 rdf:type schema:DefinedTerm
180 N7363486b6038483ea3b8d00af86aafdd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Lymphocyte Count
182 rdf:type schema:DefinedTerm
183 N840dea894a31485cb2c7d46d2d32be8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Aged
185 rdf:type schema:DefinedTerm
186 N8a6a98cb92c14a8fbbba788ae128dcdf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Risk Assessment
188 rdf:type schema:DefinedTerm
189 N8bf0e104a1c04369892c4668bce1f009 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Monocytes
191 rdf:type schema:DefinedTerm
192 N8fa8a43910bd4488bcb91f93c4399953 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Kaplan-Meier Estimate
194 rdf:type schema:DefinedTerm
195 N8fbfbf957df24c32a4eeda86cfe3d9f4 rdf:first Nea620db6fb584cc5a94e3547c5382274
196 rdf:rest N4fab78a9c3d542348a70f1f00605e7c9
197 N9c2f62048bc74a96964a3f06e6dc2abb schema:name Springer Nature - SN SciGraph project
198 rdf:type schema:Organization
199 Na22068ce13064796ab83bc984960f2f4 schema:name dimensions_id
200 schema:value pub.1126893504
201 rdf:type schema:PropertyValue
202 Naf06e03d0e004536b6c376913b660890 rdf:first N529d696075544552b50377d2c8ded4b7
203 rdf:rest N8fbfbf957df24c32a4eeda86cfe3d9f4
204 Nb44f97d796734b06815df7b4910d4087 schema:name doi
205 schema:value 10.1186/s12957-020-01847-2
206 rdf:type schema:PropertyValue
207 Nb69fa576dfd54b10a0e65c38e9c85e00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Preoperative Period
209 rdf:type schema:DefinedTerm
210 Nc2d89d1b3845453b8de3ddb39d723577 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Lymphocytes
212 rdf:type schema:DefinedTerm
213 Nc940f1b0da29480381c2ad94d46bb4f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Bile Duct Neoplasms
215 rdf:type schema:DefinedTerm
216 Nd28879f43ab84405bb5f155d3a8c73db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name Lymphatic Metastasis
218 rdf:type schema:DefinedTerm
219 Nd4a7cd1cf97c4790afebf28627f3b3f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
220 schema:name Risk Factors
221 rdf:type schema:DefinedTerm
222 Nd8a1fbd3984d4195888319a042edff2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
223 schema:name Survival Rate
224 rdf:type schema:DefinedTerm
225 Nd9d4851b5069462d8cd6c602014aa5a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
226 schema:name Retrospective Studies
227 rdf:type schema:DefinedTerm
228 Ne398474f4d754e21a06f47943efbdd24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
229 schema:name Male
230 rdf:type schema:DefinedTerm
231 Nea620db6fb584cc5a94e3547c5382274 schema:affiliation grid-institutes:None
232 schema:familyName Takashi
233 schema:givenName Shida
234 rdf:type schema:Person
235 Ned045f187f714e7d8c12f72f0c2c1300 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
236 schema:name Prognosis
237 rdf:type schema:DefinedTerm
238 Nf9271c24690844dfa348dcba36e994bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
239 schema:name Humans
240 rdf:type schema:DefinedTerm
241 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
242 schema:name Medical and Health Sciences
243 rdf:type schema:DefinedTerm
244 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
245 schema:name Oncology and Carcinogenesis
246 rdf:type schema:DefinedTerm
247 sg:journal.1032056 schema:issn 1477-7819
248 schema:name World Journal of Surgical Oncology
249 schema:publisher Springer Nature
250 rdf:type schema:Periodical
251 sg:person.0653527253.30 schema:affiliation grid-institutes:grid.136304.3
252 schema:familyName Ohtsuka
253 schema:givenName Masayuki
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653527253.30
255 rdf:type schema:Person
256 sg:person.0757552432.04 schema:affiliation grid-institutes:grid.459661.9
257 schema:familyName Shimizu
258 schema:givenName Yoshiaki
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757552432.04
260 rdf:type schema:Person
261 sg:pub.10.1007/s12032-014-0287-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1022955166
262 https://doi.org/10.1007/s12032-014-0287-y
263 rdf:type schema:CreativeWork
264 sg:pub.10.1038/nature04870 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043364117
265 https://doi.org/10.1038/nature04870
266 rdf:type schema:CreativeWork
267 sg:pub.10.1038/nature06905 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029740181
268 https://doi.org/10.1038/nature06905
269 rdf:type schema:CreativeWork
270 sg:pub.10.1038/nature07205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024729982
271 https://doi.org/10.1038/nature07205
272 rdf:type schema:CreativeWork
273 sg:pub.10.1038/nature13111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046208212
274 https://doi.org/10.1038/nature13111
275 rdf:type schema:CreativeWork
276 sg:pub.10.1038/nri1995 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052092567
277 https://doi.org/10.1038/nri1995
278 rdf:type schema:CreativeWork
279 sg:pub.10.1038/onc.2009.416 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042063808
280 https://doi.org/10.1038/onc.2009.416
281 rdf:type schema:CreativeWork
282 sg:pub.10.1186/s12885-017-3395-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085872486
283 https://doi.org/10.1186/s12885-017-3395-1
284 rdf:type schema:CreativeWork
285 grid-institutes:None schema:alternateName Shida Clinic, 1970-1-2 Ne, 270-1431, Shiroi-shi, Chiba Prefecture, Japan
286 schema:name Shida Clinic, 1970-1-2 Ne, 270-1431, Shiroi-shi, Chiba Prefecture, Japan
287 rdf:type schema:Organization
288 grid-institutes:grid.136304.3 schema:alternateName Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8677, Chiba-shi, Chiba Prefecture, Japan
289 schema:name Department of General Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8677, Chiba-shi, Chiba Prefecture, Japan
290 Department of Surgery, Japanese Red Cross Narita Hospital, 90-1 Iida-cho, 286-0041, Narita-shi, Chiba Prefecture, Japan
291 rdf:type schema:Organization
292 grid-institutes:grid.459661.9 schema:alternateName Department of Surgery, Japanese Red Cross Narita Hospital, 90-1 Iida-cho, 286-0041, Narita-shi, Chiba Prefecture, Japan
293 schema:name Department of Surgery, Japanese Red Cross Narita Hospital, 90-1 Iida-cho, 286-0041, Narita-shi, Chiba Prefecture, Japan
294 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...